Scientists are testing a promising drug that may stop a gene associated with obesity from triggering breast and lung cancer, as well as prevent them from growing. Researchers at the Michigan State University in the US showed that the drug, I-BET-762, is showing signs of significantly delaying the development of existing breast and lung cancers by zeroing in on how a cancerous gene, called c-Myc, acts. "It does this by inhibiting a number of important proteins - both in cancer and immune cells - ultimately reducing the number of cancer cells in mice by 80 percent," said the led of the two studies published in the journal Cancer Prevention Research .
These proteins are important because they play a critical role in what occurs between cells. MUST READ No relief for cancer patient on property plea For example, a particular protein, known as pSTAT3, can become activated in immune cells and…
